Superinvestor buys and sells
4,042 reductions in the latest 13F filings of the investors tracked here, largest first. The largest is Rajiv Jain's reduction of PM, $4.8B or 9.0% of the reported portfolio.
Key facts
- Reductions
- 4,042
- Largest move
- PM, $4.8B
- Investors
- 150
- Latest filing
- Nov 16, 2026
From each investor's latest 13F filing: 92 investors report Q3 2026, 65 investors report Q2 2026. Latest filing in this set: Nov 16, 2026.
| # | Investor | Stock | Move | Shares | Size | Of portfolio | Quarter |
|---|---|---|---|---|---|---|---|
| 1401 | Jim Simons (1938–2024) | Wayfair IncW | ▼ Reduced 5.0% | −227.53K | $23.3M | 0.03% | Q3 2026 |
| 1402 | Ray Dalio (founder) | Oracle CorpORCL | ▼ Reduced 10.0% | −159.04K | $23.3M | 0.10% | Q2 2026 |
| 1403 | Andreas Halvorsen | Camden Property TrustCPT | ▼ Reduced 4.3% | −202.3K | $23.2M | 0.07% | Q2 2026 |
| 1404 | Josef Lakonishok | Hartford Insurance Group IncHIG | ▼ Reduced 6.8% | −189.1K | $23.1M | 0.04% | Q3 2026 |
| 1405 | Joel Greenblatt | Dell Technologies IncDELL | ▼ Reduced 15% | −53.6K | $23.1M | 0.05% | Q2 2026 |
| 1406 | George Soros | SempraSRE | ▼ Reduced 67% | −296.39K | $23.1M | 0.36% | Q3 2026 |
| 1407 | John Rogers | Zebra TechnologiesZBRA | ▼ Reduced 6.7% | −61.84K | $23.1M | 0.24% | Q3 2026 |
| 1408 | Joel Greenblatt | NVIDIA CorpNVDA | ▼ Reduced 2.8% | −114.07K | $22.8M | 0.05% | Q2 2026 |
| 1409 | Anthony Bozza | Charles Riv Labs International IncCRL | ▼ Reduced 58% | −77.25K | $22.8M | 1.22% | Q3 2026 |
| 1410 | Chuck Royce (founder) | Andersen Group IncANDG | ▼ Reduced 37% | −418.52K | $22.8M | 0.21% | Q3 2026 |
| 1411 | Samantha McLemore | CVS Health CorpCVS | ▼ Reduced 21% | −265.5K | $22.8M | 0.76% | Q3 2026 |
| 1412 | Josef Lakonishok | CNH Indl N VCNH | ▼ Reduced 16% | −1.77M | $22.7M | 0.04% | Q3 2026 |
| 1413 | Keith Meister | Restaurant Brands International IncQSR | ▼ Reduced 20% | −313.14K | $22.7M | 0.71% | Q2 2026 |
| 1414 | Mairs & Power team | Sprouts FMRS MKT IncSFM | ▼ Reduced 76% | −342.02K | $22.7M | 0.21% | Q3 2026 |
| 1415 | Richard Pzena | Myers Industries IncMYE | ▼ Reduced 94% | −736.45K | $22.7M | 0.07% | Q3 2026 |
| 1416 | Steve Cohen | Ferrari N VRACE | ▼ Reduced 15% | −60.82K | $22.6M | 0.03% | Q2 2026 |
| 1417 | Bill Nygren | Masco CorpMAS | ▼ Reduced 3.2% | −277.67K | $22.6M | 0.03% | Q2 2026 |
| 1418 | Josef Lakonishok | United Airls Hldgs IncUAL | ▼ Reduced 7.4% | −203.17K | $22.5M | 0.04% | Q3 2026 |
| 1419 | Henry Ellenbogen | Doordash IncDASH | ▼ Reduced 2.9% | −121.87K | $22.5M | 0.22% | Q2 2026 |
| 1420 | Louis Bacon | Regal Rexnord CorporationRRX | ▼ Reduced 48% | −144.92K | $22.5M | 0.64% | Q3 2026 |
| 1421 | Jim Simons (1938–2024) | Incyte CorpINCY | ▼ Reduced 5.3% | −185.1K | $22.5M | 0.03% | Q3 2026 |
| 1422 | Cathie Wood | CareDx IncCDNA | ▼ Reduced 18% | −344.39K | $22.4M | 0.13% | Q3 2026 |
| 1423 | Steve Cohen | Madison Square Garden EntmtMSGE | ▼ Reduced 15% | −275.14K | $22.3M | 0.03% | Q2 2026 |
| 1424 | Eric Mandelblatt | American Electric Power Co. IncAEP | ▼ Reduced 14% | −162.26K | $22.2M | 0.16% | Q2 2026 |
| 1425 | Joel Greenblatt | Amkor Technology IncAMKR | ▼ Reduced 24% | −257.17K | $22.2M | 0.05% | Q2 2026 |
| 1426 | Josef Lakonishok | Bristol-Myers Squibb CoBMY | ▼ Reduced 3.6% | −354.68K | $22.1M | 0.04% | Q3 2026 |
| 1427 | John Rogers | Fiserv IncFISV | ▼ Reduced 90% | −489.69K | $22.1M | 0.23% | Q3 2026 |
| 1428 | Howard Gleicher | Cameco CorpCCJ | ▼ Reduced 24% | −254.56K | $22.1M | 0.05% | Q3 2026 |
| 1429 | Paul Tudor Jones | Allegion PLCALLE | ▼ Reduced 40% | −156.93K | $22M | 0.09% | Q2 2026 |
| 1430 | John Rogers | Madison Square Garden EntmtMSGE | ▼ Reduced 5.2% | −275.2K | $22M | 0.23% | Q3 2026 |
| 1431 | Diamond Hill team | Thermo Fisher Scientific IncTMO | ▼ Reduced 13% | −32.66K | $22M | 0.24% | Q3 2026 |
| 1432 | George Soros | Medline IncMDLN | ▼ Reduced 39% | −634.78K | $22M | 0.34% | Q3 2026 |
| 1433 | Jensen team | Cadence Design Systems IncCDNS | ▼ Reduced 22% | −66.71K | $22M | 0.69% | Q3 2026 |
| 1434 | Charles Brandes (founder) | UBS Group AGUBS | ▼ Reduced 33% | −457.63K | $22M | 0.15% | Q3 2026 |
| 1435 | Chase Coleman | UnitedHealth Group IncUNH | ▼ Reduced 15% | −52.99K | $22M | 0.09% | Q2 2026 |
| 1436 | Baillie Gifford team | Recursion Pharmaceuticals IncRXRX | ▼ Reduced 23% | −5.31M | $21.9M | 0.02% | Q3 2026 |
| 1437 | Thomas Russo | Berkshire Hathaway IncBRK-B | ▼ Reduced 4.1% | −44.04K | $21.9M | 0.26% | Q3 2026 |
| 1438 | Ken Fisher | Blackrock IncBLK | ▼ Reduced 1.5% | −20.63K | $21.8M | 0.01% | Q3 2026 |
| 1439 | Baillie Gifford team | Brookfield CorpBN | ▼ Reduced 10% | −597.84K | $21.8M | 0.02% | Q3 2026 |
| 1440 | Andrew Spokes | KKR & Co. IncKKR | ▼ Reduced 5.8% | −238.46K | $21.8M | 0.11% | Q3 2026 |
| 1441 | Rajiv Jain | Eni SpaE | ▼ Reduced 68% | −400.41K | $21.7M | 0.04% | Q3 2026 |
| 1442 | Tweedy, Browne team | Ionis Pharmaceuticals IncIONS | ▼ Reduced 21% | −486.83K | $21.7M | 1.77% | Q3 2026 |
| 1443 | Baillie Gifford team | Rivian Automotive IncRIVN | ▼ Reduced 3.4% | −1.45M | $21.7M | 0.02% | Q3 2026 |
| 1444 | Cliff Asness | Mckesson CorpMCK | ▼ Reduced 3.2% | −28.77K | $21.6M | 0.01% | Q2 2026 |
| 1445 | Andrew Spokes | AstraZeneca PLCAZN | ▼ Reduced 23% | −133.96K | $21.6M | 0.11% | Q3 2026 |
| 1446 | Ron Baron | DraftKings IncDKNG | ▼ Reduced 30% | −1.14M | $21.6M | 0.04% | Q3 2026 |
| 1447 | Louis Bacon | CSX CorpCSX | ▼ Reduced 38% | −462.92K | $21.5M | 0.61% | Q3 2026 |
| 1448 | Mairs & Power team | UnitedHealth Group IncUNH | ▼ Reduced 10% | −58.57K | $21.5M | 0.20% | Q3 2026 |
| 1449 | Matthew McLennan | Kinross Gold CorpKGC | ▼ Reduced 14% | −891.05K | $21.5M | 0.03% | Q3 2026 |
| 1450 | Baillie Gifford team | Lemonade IncLMND | ▼ Reduced 17% | −472.62K | $21.3M | 0.02% | Q3 2026 |
| 1451 | Baillie Gifford team | Mastercard IncMA | ▼ Reduced 2.2% | −38.68K | $21.3M | 0.02% | Q3 2026 |
| 1452 | George Soros | Macerich CoMAC | ▼ Reduced 49% | −951.62K | $21.3M | 0.33% | Q3 2026 |
| 1453 | Frank Sands | On Holding AGONON | ▼ Reduced 9.6% | −717.84K | $21.3M | 0.09% | Q3 2026 |
| 1454 | Steven Romick | Broadcom IncAVGO | ▼ Reduced 95% | −60.23K | $21.2M | 0.25% | Q3 2026 |
| 1455 | Chuck Royce (founder) | Element Solutions IncESI | ▼ Reduced 30% | −582.2K | $21.1M | 0.19% | Q3 2026 |
| 1456 | Wallace Weitz | Bio-Techne CorpTECH | ▼ Reduced 54% | −290.87K | $21.1M | 1.44% | Q3 2026 |
| 1457 | Lee Ainslie | Southwest Gas Holdings IncSWX | ▼ Reduced 11% | −237.37K | $21M | 0.19% | Q2 2026 |
| 1458 | Anthony Bozza | Union Pacific CorpUNP | ▼ Reduced 76% | −77.2K | $21M | 1.13% | Q3 2026 |
| 1459 | Christopher Bloomstran | Starbucks CorpSBUX | ▼ Reduced 82% | −205.54K | $21M | 2.37% | Q2 2026 |
| 1460 | Ray Dalio (founder) | Ciena CorpCIEN | ▼ Reduced 30% | −42.81K | $21M | 0.09% | Q2 2026 |
| 1461 | Sequoia Fund team | The Charles Schwab CorpSCHW | ▼ Reduced 4.7% | −214.84K | $21M | 0.34% | Q3 2026 |
| 1462 | Israel Englander | Mastercard IncMA | ▼ Reduced 5.0% | −40.86K | $21M | 0.01% | Q2 2026 |
| 1463 | Cliff Asness | Mueller Industries IncMLI | ▼ Reduced 3.5% | −170.23K | $20.9M | 0.01% | Q2 2026 |
| 1464 | Polen Capital team | Uber Technologies IncUBER | ▼ Reduced 54% | −305.31K | $20.9M | 0.23% | Q3 2026 |
| 1465 | Ron Baron | Novanta IncNOVT | ▼ Reduced 17% | −146.72K | $20.9M | 0.03% | Q3 2026 |
| 1466 | Harry Burn | Vistra CorpVST | ▼ Reduced 26% | −150.24K | $20.8M | 0.65% | Q3 2026 |
| 1467 | Ron Baron | Datadog IncDDOG | ▼ Reduced 15% | −75.74K | $20.7M | 0.03% | Q3 2026 |
| 1468 | Mairs & Power team | Tennant CoTNC | ▼ Reduced 45% | −307.93K | $20.7M | 0.19% | Q3 2026 |
| 1469 | Ron Baron | Macerich CoMAC | ▼ Reduced 19% | −924.99K | $20.7M | 0.03% | Q3 2026 |
| 1470 | Richard Pzena | Capital One Financial CorpCOF | ▼ Reduced 2.3% | −106.58K | $20.6M | 0.06% | Q3 2026 |
| 1471 | Steve Cohen | Entergy CorpETR | ▼ Reduced 10% | −178.2K | $20.5M | 0.03% | Q2 2026 |
| 1472 | Baillie Gifford team | Wix.com LtdWIX | ▼ Reduced 11% | −283.68K | $20.5M | 0.02% | Q3 2026 |
| 1473 | Ray Dalio (founder) | Vale S.A.VALE | ▼ Reduced 34% | −1.36M | $20.4M | 0.08% | Q2 2026 |
| 1474 | Lee Ainslie | Novo Nordisk A/SNVO | ▼ Reduced 20% | −426.21K | $20.4M | 0.18% | Q2 2026 |
| 1475 | Harry Burn | Bank of America CorpBAC | ▼ Reduced 18% | −374.66K | $20.4M | 0.64% | Q3 2026 |
| 1476 | Baillie Gifford team | Makemytrip LtdMMYT | ▼ Reduced 2.9% | −431.31K | $20.4M | 0.02% | Q3 2026 |
| 1477 | Baillie Gifford team | Illumina IncILMN | ▼ Reduced 5.5% | −73.88K | $20.2M | 0.02% | Q3 2026 |
| 1478 | Karthik Sarma | Credo Technology Group Holding LtdCRDO | ▼ Reduced 4.0% | −103.73K | $20.2M | 0.19% | Q3 2026 |
| 1479 | Howard Gleicher | Wal-Mart de Mexico SA Sponsno ticker on file | ▼ Reduced 31% | −786.8K | $20.2M | 0.05% | Q3 2026 |
| 1480 | Zach Schreiber | PG&E CorpPCG | ▼ Reduced 5.6% | −1.19M | $20.1M | 0.35% | Q2 2026 |
| 1481 | Josef Lakonishok | Halliburton CoHAL | ▼ Reduced 8.2% | −630.33K | $20M | 0.04% | Q3 2026 |
| 1482 | Steve Cohen | ASML Holding NVASML | ▼ Reduced 1.8% | −10.05K | $20M | 0.03% | Q2 2026 |
| 1483 | Richard Pzena | Cno Financial Group IncCNO | ▼ Reduced 15% | −377.5K | $20M | 0.06% | Q3 2026 |
| 1484 | Diamond Hill team | Post Hldgs IncPOST | ▼ Reduced 44% | −273.86K | $20M | 0.22% | Q3 2026 |
| 1485 | Bill Nygren | General Motors CoGM | ▼ Reduced 1.9% | −258.38K | $19.9M | 0.03% | Q2 2026 |
| 1486 | Jensen team | Broadcom IncAVGO | ▼ Reduced 14% | −56.5K | $19.8M | 0.62% | Q3 2026 |
| 1487 | Thomas Russo | Sunbelt Rentals Holdings IncSUNB | ▼ Reduced 4.6% | −270.71K | $19.8M | 0.24% | Q3 2026 |
| 1488 | Baillie Gifford team | Intuitive Surgical IncISRG | ▼ Reduced 1.9% | −48.72K | $19.8M | 0.02% | Q3 2026 |
| 1489 | Dodge & Cox team | Thermo Fisher Scientific IncTMO | ▼ Reduced 1.0% | −29.33K | $19.8M | 0.01% | Q3 2026 |
| 1490 | Boaz Weinstein | Tesla IncTSLA | ▼ Reduced 60% | −47.03K | $19.8M | 0.60% | Q2 2026 |
| 1491 | Rajiv Jain | Embraer SAEMBJ | ▼ Reduced 8.2% | −261.43K | $19.7M | 0.04% | Q3 2026 |
| 1492 | Ray Dalio (founder) | iShares IncEMXC | ▼ Reduced 18% | −191.72K | $19.6M | 0.08% | Q2 2026 |
| 1493 | Howard Marks | Telecom Argentina SATEO | ▼ Reduced 93% | −1.51M | $19.6M | 0.37% | Q2 2026 |
| 1494 | Diamond Hill team | L3Harris Technologies IncLHX | ▼ Reduced 18% | −82.64K | $19.6M | 0.21% | Q3 2026 |
| 1495 | Ken Fisher | Canadian Imperial Bank of CommerceCM | ▼ Reduced 6.3% | −177.31K | $19.5M | 0.01% | Q3 2026 |
| 1496 | Jim Simons (1938–2024) | Intuitive Surgical IncISRG | ▼ Reduced 9.5% | −48.02K | $19.5M | 0.03% | Q3 2026 |
| 1497 | Stephen Mandel | Argan IncAGX | ▼ Reduced 6.2% | −24.45K | $19.5M | 0.12% | Q2 2026 |
| 1498 | Mairs & Power team | Littelfuse IncLFUS | ▼ Reduced 7.6% | −45.94K | $19.5M | 0.18% | Q3 2026 |
| 1499 | Duan Yongping | Credo Technology Group Holding LtdCRDO | ▼ Reduced 14% | −99.92K | $19.5M | 0.11% | Q3 2026 |
| 1500 | Cathie Wood | Caterpillar IncCAT | ▼ Reduced 43% | −23.98K | $19.4M | 0.11% | Q3 2026 |
Questions and answers
What did superinvestors sell last quarter?
The largest sales in the latest 13F filings: PM (Rajiv Jain), $4.8B; MU (Ken Griffin), $4.6B; MU (David Shaw (founder)), $3.3B; IEF (Ken Fisher), $3.1B; CB (Rajiv Jain), $2.5B; Western Digital Corp (Israel Englander), $2.5B.
How is the size of a buy or sell worked out?
As the change in shares at the price the filing implies for the quarter's end (reported value divided by shares) — an estimate of the trade, not what was paid. A position sold out is sized at its value in the previous filing.
Learn
Cite this page
Funkfolio, “Superinvestor buys and sells”, data as of 16 November 2026. https://funkfolio.com/gurus/activity?type=reduced
Underlying data: SEC EDGAR, Form 13F-HR.
Source: SEC EDGAR, Form 13F-HR. A move is a change in share count between an investor's latest filing and the one before; a share split in between is allowed for where one is on record. Size is the shares bought or sold at the price the filing implies for the period end (reported value ÷ shares) — an estimate of the trade, not what was paid — and a position sold out is sized at its value in the previous filing. “Of portfolio” sets that size against the portfolio reported for the period. Only each investor's 150 largest positions and 50 largest exits are read. Filings appear up to 45 days after the quarter ends; none of this is advice.